Evaluation of Scoring Functions for Large Scale Application of Virtual Screening in the Identification of Novel Beta-Lactamase Inhibitors

Virtual Screening is a powerful methodology that can be used to explore large virtual databases containing millions of molecules to identify novel drug candidates with promising inhibitory activity against enzymes or receptors of medical, biological or industrial importance. Here, we report the optimization of a virtual screening protocol using atomic-level protein docking for the inhibition of Beta-lactamase, an enzyme highly associated with the development multi-drug resistance in bacteria. The results highlight the strengths and weaknesses of different virtual screening methods when dealing with this type of targets, opening the way to large-scale campaigns in the search for novel inhibitors of Beta-lactamases.

[1]  Yu-chian Chen Beware of docking! , 2015, Trends in pharmacological sciences.

[2]  António J. M. Ribeiro,et al.  Protein-ligand docking in the new millennium--a retrospective of 10 years in the field. , 2013, Current medicinal chemistry.

[3]  A. Cavalli,et al.  Dynamic Docking: A Paradigm Shift in Computational Drug Discovery , 2017, Molecules.

[4]  Diogo Santos-Martins,et al.  Receptor-based virtual screening protocol for drug discovery. , 2015, Archives of biochemistry and biophysics.

[5]  Jonathan W. Essex,et al.  A review of protein-small molecule docking methods , 2002, J. Comput. Aided Mol. Des..

[6]  R. Kroemer Structure-based drug design: docking and scoring. , 2007, Current protein & peptide science.

[7]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[8]  Michael M. Mysinger,et al.  Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.

[9]  Pedro Alexandrino Fernandes,et al.  Protein–ligand docking: Current status and future challenges , 2006, Proteins.

[10]  J. Irwin,et al.  Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.

[11]  Robin Taylor,et al.  Comparing protein–ligand docking programs is difficult , 2005, Proteins.

[12]  Ajay N. Jain,et al.  Scoring functions for protein-ligand docking. , 2006, Current protein & peptide science.

[13]  Gisbert Schneider,et al.  Virtual screening and fast automated docking methods. , 2002, Drug discovery today.

[14]  Xiaoqin Zou,et al.  Advances and Challenges in Protein-Ligand Docking , 2010, International journal of molecular sciences.

[15]  Chung F. Wong,et al.  Flexible receptor docking for drug discovery , 2015, Expert opinion on drug discovery.

[16]  Leonardo L. G. Ferreira,et al.  Molecular Docking and Structure-Based Drug Design Strategies , 2015, Molecules.

[17]  Maria João Ramos,et al.  Virtual screening in drug design and development. , 2010, Combinatorial chemistry & high throughput screening.

[18]  Anna E Lohning,et al.  A Practical Guide to Molecular Docking and Homology Modelling for Medicinal Chemists. , 2017, Current topics in medicinal chemistry.

[19]  Ruth Nussinov,et al.  Principles of docking: An overview of search algorithms and a guide to scoring functions , 2002, Proteins.

[20]  Victoria T Lim,et al.  Quantum-Mechanics Methodologies in Drug Discovery: Applications of Docking and Scoring in Lead Optimization. , 2017, Current topics in medicinal chemistry.

[21]  Mahmoud E S Soliman,et al.  Implementing QM in docking calculations: is it a waste of computational time? , 2017, Drug discovery today.